Unlock stock picks and a broker-level newsfeed that powers Wall Street.
1.8253
-0.0047
(-0.26%)
As of 11:40:45 AM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| Currency in USD | 3/31/2023 | 6/30/2023 |
|---|---|---|
| EPS Est. | -2.4 | -0.3 |
| EPS Actual | -4.1 | -2.7 |
| Difference | -1.7 | -2.4 |
| Surprise % | -70.83% | -800.00% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CELU | -- | -- | -- | -- |
| S&P 500 | 16.20% | 6.69% | 10.00% | 14.33% |
Related Tickers
SRNE Sorrento Therapeutics, Inc.
0.0007
0.00%
AARD Aardvark Therapeutics, Inc. Common Stock
7.11
-8.21%
PRLD Prelude Therapeutics Incorporated
0.8305
+3.81%
ZNTL Zentalis Pharmaceuticals, Inc.
1.6100
-11.05%
ENTO Entero Therapeutics, Inc.
0.5080
+1.76%
LXEO Lexeo Therapeutics, Inc.
3.6987
-9.79%
VINC Vincerx Pharma, Inc.
0.5100
-5.40%
MOLN Molecular Partners AG
4.3500
+6.10%
FBRX Forte Biosciences, Inc.
8.66
+5.64%
CYCN Cyclerion Therapeutics, Inc.
2.4500
-3.92%